Characteristic computed tomography features in mesenchymal-epithelial transition exon14 skipping-positive non-small cell lung cancer

BACKGROUND: Mesenchymal-epithelial transition exon14 (METex14) skipping is one of the therapeutic driver oncogene mutations in non-small cell lung cancer (NSCLC), and can be treated with tepotinib and capmatinib. There is only one report on computed tomography (CT) findings of METex14 skipping-posit...

Descripción completa

Detalles Bibliográficos
Autores principales: Watari, Naokazu, Yamaguchi, Kakuhiro, Terada, Hiroaki, Hamai, Kosuke, Masuda, Ken, Nishimura, Yoshifumi, Sakamoto, Shinjiro, Masuda, Takeshi, Horimasu, Yasushi, Miyamoto, Shintaro, Nakashima, Taku, Iwamoto, Hiroshi, Shoda, Hiroyasu, Ishikawa, Nobuhisa, Fujitaka, Kazunori, Miyazaki, Kozue, Miyata, Yoshihiro, Hamada, Hironobu, Awai, Kazuo, Hattori, Noboru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245203/
https://www.ncbi.nlm.nih.gov/pubmed/35773658
http://dx.doi.org/10.1186/s12890-022-02037-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245203/
https://www.ncbi.nlm.nih.gov/pubmed/35773658
http://dx.doi.org/10.1186/s12890-022-02037-4

Ejemplares similares